-
Clorazepate monopotassium
- names:
1H-1,4-Benzodiazepine-3-carboxylic acid, 2,3-dihydro-7-chloro-2-oxo-5-phenyl-, monopotassium salt
- CAS号:
5991-71-9
MDL Number: - MF(分子式): C16H10ClKN2O3 MW(分子量): 352.8153
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | Clorazepate monopotassium |
| 英文别名 | Clorazepate monopotassium; Abbott-39083; Abbott 39083; Abbott39083 |
| CAS号 | 5991-71-9 |
| Inchi | InChI=1S/C16H11ClN2O3.K/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;/h1-8,14H,(H,18,20)(H,21,22);/q;+1/p-1 |
| InchiKey | ULEUKTXFAJZAAV-UHFFFAOYSA-M |
| 分子式 Formula | C16H10ClKN2O3 |
| 分子量 Molecular Weight | 352.8153 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Clorazepate monopotassium(CAS:5991-71-9):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Clorazepate monopotassium is a minor tranquilizer. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Clorazepate. 2018 Oct 3[1]PMID: 30000269. |
| [2]Hanna S, Diana F, Slevinski J, Veronich K, Lachman L. Differential pulse polarographic determination of clorazepate monopotassium and dipotassium. J Pharm Sci. 1978 Dec;67(12):1723-5. doi: 10.1002/jps.2600671224. PMID: 31451. |
| [3] Cohn JB, Bowden CL, Fisher JG, Rodos JJ. Double-blind comparison of buspirone and clorazepate in anxious outpatients. Am J Med. 1986 Mar 31;80(3B):10-6. doi: 10.1016/0002-9343(86)90326-8. PMID: 2870640. |
| [4] Fujii T, Okuno T, Go T, Ochi J, Hattori H, Kataoka K, Mikawa H. Clorazepate therapy for intractable epilepsy. Brain Dev. 1987;9(3):288-91. doi: 10.1016/s0387-7604(87)80046-3. PMID: 2889387. |
| [5] Elrod L Jr, Shada DM, Taylor VE. High-performance liquid chromatographic analysis of clorazepate dipotassium and monopotassium in solid dosage forms. J Pharm Sci. 1981 Jul;70(7):793-5. doi: 10.1002/jps.2600700721. PMID: 6115049. |
6: Forrester SD, Brown SA, Lees GE, Hartsfield SM. Disposition of clorazepate in dogs after single- and multiple-dose oral administration. Am J Vet Res. 1990 Dec;51(12):2001-5. PMID: 2085227.7: Bartenbach DE. Clorazepate dipotassium. Am Fam Physician. 1978 Oct;18(4):43,46,50. PMID: 30272.8: Mimaki T, Tagawa T, Ono J, Tanaka J, Terada H, Itoh N, Yabuuchi H. Antiepileptic effect and serum levels of clorazepate on children with refractory seizures. Brain Dev. 1984;6(6):539-44. doi: 10.1016/s0387-7604(84)80097-2. PMID: 6152517.9: Suzuki EM, Gresham WR. Identification of some interferences in the analysis of clorazepate. J Forensic Sci. 1983 Jul;28(3):655-82. PMID: 6137507.10: Livingston S, Pauli LL. Clorazepate in epilepsy. JAMA. 1977 Apr 11;237(15):1561. PMID: 15140.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


